期刊文献+

EphA2、EphrinA1在原发性肝细胞癌组织中的表达及与血管生成的关系

THE EXPRESSION OF EphA2、EphrinA1 AND THE RELATIONS OF ANGIOGENESIS IN PHC TISSUES
下载PDF
导出
摘要 目的了解EphA2与其配体EphrinA1在原发性肝细胞癌组织中的表达及与肿瘤血管生成的关系。方法利用免疫组化方法检测43例原发性肝细胞癌手术切除标本中癌组织、癌旁组织及正常肝组织EphA2、EphrinA1的表达,并采用CD34抗体标记计算微血管密度(MVD)。分析EphA2、EphrinA1的表达与MVD之间的相关性。结果原发性肝癌组织中EphA2、EphrinA1的表达及MVD显著高于癌旁组织及正常肝组织(P<0.05);MVD值与肿瘤直径有关(P<0.05),等级相关分析表明,EphA2、EphrinA1表达分别与MVD呈显著正相关(r=0.683,P<0.01;r=0.492,P<0.01)。结论EphA2及其配体EphrinA1在原发性肝细胞癌组织中呈特异性高表达,提示其可能参与肿瘤血管的生成。 Objective To detect the expression of EphA2 and its ligand - -EphrinAl with immunohisto- chemistry and determine the relations of angiogenesis . Methods We' ve detected the expressions of EphA2 and EphrinA1 in carcinoma , paracarcinoma and normal tissues in 43 cases with PHC(primary hepatic carcinoma)and calculated MVD(micro- vessel density) marked with CD34 antibody . The correlations between the expression of EphA2 and EphrinA1 and MVD is analyzed . Results the expressions of EphA2 , EphrinA1 in PHC tissues and MVD is significantly higher than that in paraearcinoma and normal tissues ( P 〈 0.05 ) ; MVD values are correlated with the diameters of tumors(P 〈0.05)and the expressions of EphA2 , EphrinA1 are positively correlated significantly with MVD , respectively( r = 0.683, P 〈 0. Ol ; r = 0. 492, P 〈 0.01 ). Conclusion EphA2 and its ligand - EphrinA1 are specificly expressed with a high level in PHC and may take an important role in angiogenesis and maliogenesis of PHC.
作者 周为 张宇
出处 《青海医学院学报》 CAS 2009年第1期32-35,72,共5页 Journal of Qinghai Medical College
关键词 原发性肝细胞癌 EPHA2 EPHRINA1 血管生成 Primary hepatic carcinoma (PHC) EphA2 EphrinA1 Angiogenesis
  • 相关文献

参考文献14

  • 1Chang Q,Jorgensen C,Pawson T,et al. Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer[J].Br J Cancer, 2008,99(7):1074-82
  • 2Noblitt LW,Bangari DS, Shukla S,et al. Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy[J].Cancer Gene Ther,2005,12(1):46-53
  • 3Cheng N, Brantley DM,Liu H,et al. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis [J]. Mol Cancer Res, 2002,1(1):2-11
  • 4Carles-Kinch K, Kilpatrick KE,Stewart JC,et al. Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior[J].Cancer Res,2002,62(10):2840-2847
  • 5Mudali SV,Fu B,Lakkur SS,et al. Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status[J].Clin Exp Metastasis,2006,23(7-8):357-365
  • 6Wykosky J, Gibo DM, Debinski W.A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells[J].Mol Cancer Ther,2007 ,6(12 Pt 1):3208-3218
  • 7Wykosky J,Gibo DM, Stanton C,et al. Interleukin-13 receptor alpha 2, EphA2, and Fos-related antigen 1 as molecular denominators of high-grade astrocytomas and specific targets for combinatorial therapy[J].Clin Cancer Res,2008,14(1):199-208
  • 8Wykosky J, Gibo DM,Stanton C,et al. EphA2 as a novel molecular marker and target in glioblastoma multiforme[J].Mol Cancer Res,2005,3(10):541-551
  • 9Nakamura R,Kataoka H,Sato N,et al. EPHA2/EFNA1 expression in human gastric cancer[J].Cancer Sci,2005,96(1):42-47
  • 10Kojima T,Chung TY,Chang JH,et al. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas[J].Cornea,2007,26(5):569-578

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部